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ABSTRACT
Objective: A retrospective study was conducted in a tertiary care hospital collaborated with a medical college, to analyze the drug therapy including 
antidotes administered and pattern of Organophosphorous compounds poisoning.
Methods: The data are analytically drawn from record sheets of Organophosphorous poisoning patients. The collected tabulated data were statistically 
analyzed with SPSS version for the pattern of Organophosphorous compounds poisoning.
Results: The demographic data of 122 Organophosphorous poisoning clinical cases documented 84.42% suicidal tendency and 15.57% accidental 
exposure of patients, 66.39% in the age of 15–24 years, and 70.49% were female and 70.49% from a rural background, and 29.50% from an urban 
background. Before pharmacotherapy, all patients were subjected to general supportive measures including stomach wash, and patients were 
administered pharmacotherapy consisting of Pralidoxime (23.77%) and Atropine (41.80%).
Conclusion: This present concluded that patients diagnosed with Organophosphorous poisoning can be managed by alone administration of atropine 
as an antidote which is available as a cost-effective drug as compared to Pralidoxime. Thus, cost-effectiveness can be significantly reduced by the 
rational drug use and strict implementation of the pesticide act to further strengthen the proper maintenance of procurement of Organophosphorous 
compounds for exclusively agricultural purposes.
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INTRODUCTION
Organophosphorous poisoning is posing a huge increase in suicidal and 
accidental poisoning and is found in increased incidence and prevalence 
in developing countries. The poisoning could be attributable via the 
transdermal route, oral route, or respiratory route [1-2]. The rapid 
industrialization, massive use of pesticides in the agriculture sector, and 
introduction of a newer range of drugs for pharmacotherapy have increased 
the incidence of poisoning cases. In the developed world the poisoning 
deaths are attributed to paracetamol, household detergents, cleansing 
surfactants and reagents, carbon monoxide, and other cosmetically used 
products, but contrary in India as agriculture is the mainstay of occupation, 
agrochemical related fertilizers, insecticides are used to a much greater 
extent and poisoning by these agents are of thereof choice [3,4]. According 
to various studies, organophosphate forms the most common substantial 
poison consumed for suicidal poisoning. Poisoning contributes to the 
fourth most common cause of significant mortality in India [5].
Organophosphorous poisoning results from consumption or thereto 
exposure to hazardous deleterious Organophosphorous compounds. 
These Organophosphorous compounds are a group of chemical 
compounds used in industrial, domestic, and agricultural sectors. 
Organophosphorous compounds are commonly used household 
insecticides and are extensively used in the horticulture and agriculture 
sector. They are used worldwide and massively used in India 
too [6-8]. The most commonly used Organophosphorous compounds 
include tetrachlorvinphos, dichlorvos, parathion, malathion, fenitrothion, 
chlorpyrifos, azinphosmethyl [9-10]. Parathion and methyl parathion 
being having low volatility and stability in an aqueous solution and are thus 
widely used insecticides in the agricultural sector. After a local exposure 
to aerosols or vapors or after inhalation, respiratory and ocular effects 
generally appear first in order of symptoms. The ocular manifestations 
include miosis, conjunctival congestion, ocular pain, ciliary spasm, brow 
ache, and diminished vision. However, with acute systemic absorption 
miosis may not be present due to sympathetic discharge as a response to 
hypotension. In addition to hyperemia of the upper respiratory tract, the 
respiratory manifestations include tightness in the chest and wheezing/
rales while auscultation, which is caused by the combination of increased 
bronchial secretions and bronchoconstriction [11].
For easy availability and access to household Organophosphorous 
compounds are one of the major products amounting to suicidal 
poisoning and thus causing significant morbidity and mortality, 
especially in India [6-8,15-17]. The suicidal tendency among the 
rural Indian population is very common. In Haryana, a native state of 
India, Organophosphorous compounds poisoning has become a major 
massacre killer [15-17]. The reduction of psychological stress may at 
times result in a decrease in the incidence and prevalence of suicidal 
death tendency. Despite primary prevention and primary intervention 
in the developing world, it is difficult to tackle this menace. Thus, 
it is well understood to treat clinical cases of Organophosphorous 
poisoning in tertiary care hospitals to reduce the morbidity and 
subsequent mortality posed by Organophosphorous compounds. 
Although complete removal of Organophosphorous compounds from 
home which are widely and readily available at moments of stress may 
favor a reduction in suicidal death rates [17].
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The core pharmacotherapy of Organophosphorous poisoning constitutes 
Atropine, a central and peripheral muscarinic receptor antagonist, and 
another antidote called Pralidoxime (cholinesterase reactivation) [18-20]. 
Organophosphorous compounds exhibit their effects via inhibition of 
acetylcholinesterase which results in the accumulation of acetylcholine 
in the synaptic clefts of cholinergic synapses. Overall clinical presentation 
of the patient depends upon the type and nature of Organophosphorous 
compound and its route of exposure/intake and patient hospitalization 
and the category of the patient itself in context with mild, moderate, 
or severe poisoning [10,18]. According to well-documented literature 
to improve prognosis, immediate use of antidote is recommended 
in every established case of Organophosphorous poisoning. Till now 
very few studies have been done to visualize the present situation of 
Organophosphorous poisoning and its pharmacotherapy module, thus 
this present retrospective study is conducted to see the rational drug 
usage of available antidotes and the rate of suicidal death prevention.
Aims and objectives
1. To analyze the possible causal relationship of the demographic 
profile of patients of Organophosphorous poisoning and type of 
Organophosphorous compounds ingested and subsequent prognosis 
after pharmacotherapy with subsequent antidotes
2. To observe and document the ultimate fate of Organophosphorous 
poisoning patients
3. To analyze the rational drug usage of Atropine and Pralidoxime for 
patients with Organophosphorous poisoning.
Table 1: Clinical features of organophosphorous compounds poisoning 
[12-14]. A retrospective study was conducted in a tertiary care 
hospital, a constituent unit of maharishi Markandeshwar deemed to 
be a university at the department of forensic medicine in collaboration 
with the department of pharmacology. The data was collected from the 
record of then hospitalized patients and records were therefore tracked 
and recorded for those diagnosed with Organophosphorous poisoning. 
The study protocol was approved by the institutional ethics committee 
before the initiation of the study. The relevant key information in 
the questionnaire includes gender (male, female, others), age, date 
and time of admission, time of ingestion of Organophosphorous 
compounds, the reason for poisoning, the type of poison, poisoning 
route, relevant patient status including marital, management including 
pharmacotherapy of patient, hospitalized duration of a patient, and the 
outcome of the patient. The cases with incomplete information were 
excluded from the study. The data were collected from the medical 
record department from September 1, 2019, to November 31, 2020, in 
a case record format. The collected data were analyzed for demographic 
pattern, Organophosphorous compound ingested, treatment module, 
including drug therapy, and other relevant supportive measures in 
context with the maintenance of airway, breathing, and circulation. 
Further clinical outcomes in form of atropinization and final treatment 
outcomes were tabulated and documented. The final data was 
compiled and subjected to statistical data analysis by using appropriate 
descriptive statistical methods by using the SPSS version.
RESULTS
During the study period, the data of 122 patients with Organophosphorous 
compound poisoning was collected. Of the 122 patients, 86 (70.49%) 
were females and 36 (29.50%) were males as demonstrated in Table 1.
The documented records reveal chlorpyriphos, phorate, parathion, and 
malathion as the most frequently used Organophosphorous compounds as 
poisons. The reason stated for Organophosphorous compound poisoning 
was a suicidal attempt in 103 patients (84.42%) and accidental exposure 
to organophosphorus poisoning (OPC) accounts for 19 patients (15.57%) 
as depicted in Table 2. The demographic pattern of organophosphorous 
poisoning is demonstrated in Table 3, whereas factors responsible for 
organophosphorous poisoning is well projected in Table 4.
As documented the final diagnosis depends on the history/information 
received from the patient itself or patient attendants/family members 
on the mode of exposure, duration of exposure, and how the patient 
conducted the OPC poisoning. The management of the patient was 
done according to set international protocols. After the removal of body 
clothes, the body of the patient was thoroughly washed with water and 
soap. All, the natural orifices were cleaned, irrigated, and washed with 
copious amounts of saline and water. A gastric tube was inserted to 
perform gastric lavage and subsequent with a nasogastric tube, stomach 
wash, and irrigation was subsequently performed. Simultaneously, the 
intravenous line was drawn and the blood samples for arterial blood gas 
analysis including the gastric lavage content were sent for laboratory 
examination. The patient is further stabilized with the maintenance of 
fluids and electrolytes as such extensive intravenous fluids were given and 
forced diuresis was performed. The administration of charcoal was done. 
The patients requiring ventilator support were given positive pressure 
ventilation with intubation. The drug therapy includes the administration 
of atropine and Pralidoxime as an antidote as per the recommended 
dosage schedule. A starting dose of 1–2 mg of atropine and a subsequent 
maintenance dose of 0.52 mg was repeated depending upon individual 
outcomes of the patient. The Pralidoxime was infused at 4 mg/kg/h for 
48 h. 70.49% of patients improved after atropine is administered. Another 
set of patients were prescribed steroid therapy 11.47%; benzodiazepines 
9.01% and methylxanthines 9.1% along with antidote therapy.
DISCUSSION
The use of Organophosphorous compounds is widespread in developing 
countries like India, to increase the availability of crop production 
Table 1: Clinical features of organophosphorous compounds 
poisoning [12‑14]
A. Clinical features due to overstimulation of nicotinic acetylcholine 





B. Clinical features due to overstimulation of muscarinic 









C. Clinical features due to overstimulation of nicotinic acetylcholine 




D. Clinical features due to overstimulation of muscarinic and 





Table 2: The clinical features of 122 patients diagnosed with 
organophosphorous poisoning
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and to maintain the demand and supply chain of agricultural goods. 
Organophosphorous compounds are largely been used as pesticides all 
over the world [21]. The increased availability of Organophosphorous 
compounds has subsequently increased the incidence of ingestion 
resulting in OPC poisoning [2]. Organophosphorous compound poisoning 
is a preventable public health issue in developing countries [21]. The 
Fig. 1 demonstrates that the pattern of organophosphorous poisoning 
is greater in female patients (70.5 %) as compared to male patients 
(29.5 %) in context with gender  distribution. The present study found 
atropine as an effective antidote along with oxygen therapy, our study 
just coincides with a study conducted by L.A. konickx which concluded 
that early atropinization must be implemented as soon as possible while 
treating the patient even if oxygen therapy is available or not [22]. In the 
adjacent surrounding demographic area of this tertiary care hospital, 
agriculture reserves the main source of income, and these rural people 
are dependent on this livelihood. Agriculture farming implies the use of 
Organophosphorous compounds as a pesticide. As such there is not much 
regulation in the sale and purchase of Organophosphorous compounds 
over here, thus much easy availability with no restrictions poses a direct 
threat, our study results just coincide with the study conducted by Saadeh 
et al. which demonstrates that ready availability of Organophosphorous 
compounds poses a huge threat while procurement of Organophosphorous 
compounds [23]. Although psychosocial therapy with counseling and 
awareness can be helpful pharmacotherapy and management in hospitals 
will be the key core treatment module of these suicidal preventions. The 
Fig. 2 illustrates the cause for organophosphorous poisoning. The reason 
stated for Organophosphorous compound poisoning was a suicidal 
attempt in 103 patients (84.42%) and accidental exposure to OPC 
accounts for 19 patients (15.57%), which implies the high level of suicidal 
tendency with Organophosphorous compounds, these findings correlate 
and coincides with the findings performed by Sungur and Guven which 
demonstrates the easy ease of availability has resulted in a high level of 
accidental and suicidal poisoning [24].
In this present study, patients were given generalized supportive 
measures by ensuring the maintenance of patency of airways, breathing, 
and hemodynamic circulation. Further Atropine and Pralidoxime 
reserves the choice of antidote therapy in Organophosphorous 
poisoning, as depicted in Table 5 [6,20]. Further, a lot of debate 
has already been done in terms of the most effective strategy of 
pharmacotherapy, as such atropine as the only drug was used in 
the past for the management of patients with Organophosphorous 
poisoning [6,8,15,20,25-26]. Thus atropine therapy alone is helpful for 
the management of Organophosphorous poisoning and suicidal death 
prevention. In this present study nicotinic symptom viz. Tachycardia 
was seen as 29 % and muscarinic symptoms as 45%, our study results 
just coincide with Ozturk et al. which performed an Anticholineesterase 
study poisoning in the turkey-clinical laboratory and radiological 
evaluation of 269 cases and demonstrates similar results in context 
with clinical features [27]. The administration of Pralidoxime to 23.77% 
of patients has not concluded any as such beneficial effect, also oximes 
are the class of expensive drugs and yields some major side effects. 
The peculiar clinical feature for muscarinic symptom miosis was: 28% 
which was less documented as compared to Ozturk et al. which resulted 
in 80.66% of miosis in hospitalized patients when the retrospective 
analysis was performed for the hospitalized patients in their hospital 
for over a period of 10 years. The difference in prognosis depends upon 
the type of specific pesticides constituents [7,18]. Patients developed 
respiratory depression after from cholinergic crisis load, while they 
were in a conscious state as seen and documented by the Glasgow 
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Table 4: Factors responsible for Organophosphorous poisoning 
in 103 suicidal poisoning patients
Factors Frequency (%)
Financial issue 44 (42.71)
Family dispute 27 (26.21)
Marital dispute 22 (21.35)
Mental retarded 10 (9.70)
Total 103 (100)






Decontamination (gastric lavage and charcoal) 22 (18.03)
Maintenance of airway, breathing, circulation 
including gastric acid neutralizing drugs
20 (16.39)
OPC: Organophosphorus poisoning
Fig. 1 : Gender distribution in organophosphorus poisoning
Fig. 2: Cause for organophosphorus poisoning
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coma scale. This was the most important cause of morbidity who were 
admitted and treated in this hospital in our study [6,8,18].
CONCLUSION
Organophosphorous associated death prevention may be prevented by 
strict implementation of the pesticide act which constitutes manufacture, 
transport, sale, distribution, and use of pesticides under scrutinized 
guidelines; also ‘poison information center’ must be effectively working 
in each district; the emergency department must be equipped with 
necessary arrangements and antidotes to combat clinical poisoning 
suspects; most importantly psychosocial information, education, and 
rehabilitation by government/non-government agencies must work 
effectively to educate the people and other psychosocial issues must 
be resolved at par possible. Appropriate management with effective 
pharmacotherapy constituted with the administration of atropine 
alone as an antidote, adjuvant pharmacotherapy with other drug 
categories: benzodiazepines, xanthenes, and parenteral steroids must 
be implemented as and when required. The use of Pralidoxime must be 
restricted as such it is an expensive drug. Thus cost-effectiveness may 
be reduced and suicidal death could be prevented with an improved 
treatment module of Organophosphorous poisoning.
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